- Home
- LUNG vs JPI Comparison
LUNG vs JPI Comparison
Compare LUNG & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- JPI
- Stock Information
- Founded
- LUNG 1995
- JPI 2012
- Country
- LUNG United States
- JPI United States
- Employees
- LUNG N/A
- JPI N/A
- Industry
- LUNG Industrial Specialties
- JPI Finance Companies
- Sector
- LUNG Health Care
- JPI Finance
- Exchange
- LUNG Nasdaq
- JPI Nasdaq
- Market Cap
- LUNG 251.5M
- JPI 289.6M
- IPO Year
- LUNG 2020
- JPI N/A
- Fundamental
- Price
- LUNG $6.23
- JPI $19.74
- Analyst Decision
- LUNG Buy
- JPI
- Analyst Count
- LUNG 6
- JPI 0
- Target Price
- LUNG $11.92
- JPI N/A
- AVG Volume (30 Days)
- LUNG 252.9K
- JPI 54.7K
- Earning Date
- LUNG 02-19-2025
- JPI 01-01-0001
- Dividend Yield
- LUNG N/A
- JPI 6.15%
- EPS Growth
- LUNG N/A
- JPI N/A
- EPS
- LUNG N/A
- JPI N/A
- Revenue
- LUNG $79,302,000.00
- JPI N/A
- Revenue This Year
- LUNG $22.26
- JPI N/A
- Revenue Next Year
- LUNG $18.72
- JPI N/A
- P/E Ratio
- LUNG N/A
- JPI N/A
- Revenue Growth
- LUNG 22.34
- JPI N/A
- 52 Week Low
- LUNG $5.46
- JPI $16.02
- 52 Week High
- LUNG $14.84
- JPI $19.12
- Technical
- Relative Strength Index (RSI)
- LUNG 41.37
- JPI 30.84
- Support Level
- LUNG $5.72
- JPI $20.28
- Resistance Level
- LUNG $6.28
- JPI $21.09
- Average True Range (ATR)
- LUNG 0.40
- JPI 0.35
- MACD
- LUNG -0.03
- JPI -0.10
- Stochastic Oscillator
- LUNG 19.85
- JPI 15.87
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.